NCT00049725
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
- Locations
-
- Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States
Clinical trial condition
Purpura, Thrombocytopenic
Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.
339 public trials
90 recruiting studies
Purpura, Thrombocytopenic trial results
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
NCT00151840
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
- Locations
-
- Hematology Clinic, Medical University of Bialystok Bialystok, Poland
- Haematology Clinic, Medical University of Gdansk Gdansk, Poland
- Clinic of Haematology, Medical University of Lodz Lodz, Poland
- Clinical of Internal Diseases and haematology with Bone marrow Transplantation Unit, Central Academic Hospital, Medical Military Academy Warsaw, Poland
NCT00002250
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +29 more
- Locations
-
- San Francisco Gen Hosp San Francisco, California, United States
Active, Not Recruiting
An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias
NCT05757570
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +22 more
- Locations
-
- Investigational Site (230) Los Angeles, California, United States
- Investigational Site (401) Washington D.C., District of Columbia, United States
- Investigational Site (419) Cooper City, Florida, United States
- Investigational Site (425) Miami, Florida, United States
Active, Not Recruiting
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
NCT05653219
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Yuma Regional Medical Center Yuma, Arizona, United States
- University of Colorado Anschutz Aurora, Colorado, United States
- NorthShore University Health System Evanston, Illinois, United States
- Boston Medical Center Boston, Massachusetts, United States
Active, Not Recruiting
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
NCT05653349
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Yuma Regional Medical Center Yuma, Arizona, United States
- Community Cancer Institute Clovis, California, United States
- Compassionate Care Res Group Inc Fountain Valley, California, United States
- University of Colorado Anschutz Aurora, Colorado, United States
Active, Not Recruiting
MICROVASCULAR DAMAGE IN THROMBOTIC THROMBOCYTOPENIC PURPURA
NCT07615244
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
- Locations
-
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milano, Italy
Active, Not Recruiting
Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP
NCT04985318
- Conditions
- Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
- Locations
-
- University Hospital of Cologne Cologne, Germany
Active, Not Recruiting
A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies
NCT05885555
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Med Center Boston, Massachusetts, United States
- Novartis Investigative Site CABA, Argentina
- Novartis Investigative Site Garran, Australian Capital Territory, Australia